ArticleJournal of molecular biomarkers & diagnosis2014

Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer.

Lian Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.